Status:
UNKNOWN
Improving HIV Diagnosis, Linkage to Care, and Prevention Services With HIV Point-of-Care Nucleic Acid Tests
Lead Sponsor:
University of Washington
Collaborating Sponsors:
Centers for Disease Control and Prevention
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This project will develop, implement, and evaluate models for use of point-of-care nucleic acid testing (POC NAT) among HIV-negative persons seeking HIV testing, PEP, and PrEP and HIV-positive persons...
Eligibility Criteria
Inclusion
- Persons who are HIV-positive and seeking care at Madison Clinic.
- 18 years of age or older
- Patient's provider is willing to deliver adherence intervention
- Patient is getting a laboratory RNA viral load test that day.
- Able to read and speak English
Exclusion
- Patients of unknown HIV status
- Patients who have participated in the study before
Key Trial Info
Start Date :
January 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2024
Estimated Enrollment :
932 Patients enrolled
Trial Details
Trial ID
NCT04880200
Start Date
January 3 2022
End Date
August 31 2024
Last Update
April 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Madison Clinic
Seattle, Washington, United States, 98104